These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38819501)

  • 1. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
    Navarro P; Feo-Ortega S; Casabona-Francés S; Gutiérrez-Junquera C; Savarino EV; Amorena E; Fernández-Fernández S; Pérez-Martínez I; Oliva S; Barrio J; Masiques-Mas ML; Guardiola-Arévalo A; Guagnozzi D; Racca F; Betoré E; Votto M; Rodríguez-Sánchez A; Barrio ML; Blas-Jhon L; Sánchez-Vegazo CT; García-Morales N; Krarup AL; Dainese R; Martín-Dominguez V; García-Díaz A; Maniero D; Santander C; Arias Á; Laserna-Mendieta EJ; Lucendo AJ
    Eur J Pediatr; 2024 Aug; 183(8):3567-3578. PubMed ID: 38819501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
    Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
    Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.
    Laserna-Mendieta EJ; Casabona S; Guagnozzi D; Savarino E; Perelló A; Guardiola-Arévalo A; Barrio J; Pérez-Martínez I; Lund Krarup A; Alcedo J; de la Riva S; Rey-Iborra E; Santander C; Arias Á; Lucendo AJ;
    Aliment Pharmacol Ther; 2020 Sep; 52(5):798-807. PubMed ID: 32677040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
    Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
    United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice.
    Laserna-Mendieta EJ; Casabona S; Savarino E; Perelló A; Pérez-Martínez I; Guagnozzi D; Barrio J; Guardiola A; Asensio T; de la Riva S; Ruiz-Ponce M; Rodríguez-Oballe JA; Santander C; Arias Á; Lucendo AJ;
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2903-2911.e4. PubMed ID: 31988045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil-Derived Neurotoxin Predicts Response to Proton-Pump Inhibitor Treatment in Pediatric Eosinophilic Esophagitis.
    Irastorza LE; Hopson P; Nabar S; Deb C; Smadi Y
    J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):267-271. PubMed ID: 34321427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.
    Frandsen LT; Westmark S; Melgaard D; Krarup AL
    United European Gastroenterol J; 2021 Oct; 9(8):910-918. PubMed ID: 34477326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician.
    Feo-Ortega S; Lucendo AJ
    Therap Adv Gastroenterol; 2022; 15():17562848211068665. PubMed ID: 35069803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
    Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
    Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Borrell B; Román E
    J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):210-216. PubMed ID: 29509636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of eosinophilic esophagitis.
    Franciosi JP; Gordon M; Sinopoulou V; Dellon ES; Gupta SK; Reed CC; Gutiérrez-Junquera C; Venkatesh RD; Erwin EA; Egiz A; Elleithy A; Mougey EB
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD004065. PubMed ID: 37470293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
    Munoz-Persy M; Lucendo AJ
    Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative long-term treatment of children with eosinophilic esophagitis.
    Levine J; Lai J; Edelman M; Schuval SJ
    Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.
    Rajan J; Newbury RO; Anilkumar A; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2016 Jan; 137(1):147-156.e8. PubMed ID: 26233926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food elimination diet is a viable alternative therapy for eosinophilic esophagitis responsive to proton pump inhibitors.
    Sia T; Cunningham E; Miller M; Nitschelm R; Tanaka R; Epstein T; Garrett K; Huang A; Pak D; Scheve A; Leung J
    BMC Gastroenterol; 2023 Mar; 23(1):60. PubMed ID: 36890481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors in eosinophilic esophagitis (EoE) related to oral immunotherapy: is it as effective as in other EoE?
    Shalem T; Cohen DL; Epstein-Rigbi N; Elizur A; Eindor-Abarbanel A; Broide E; Richter V
    Eur J Pediatr; 2023 Dec; 182(12):5409-5416. PubMed ID: 37750913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use.
    Greuter T; Alexander JA; Straumann A; Katzka DA
    Clin Transl Gastroenterol; 2018 Dec; 9(12):e212. PubMed ID: 30802222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study.
    Greuter T; Godat A; Ringel A; Almonte HS; Schupack D; Mendoza G; McCright-Gill T; Dellon ES; Hirano I; Alexander J; Chehade M; Safroneeva E; Bussmann C; Biedermann L; Schreiner P; Schoepfer AM; Straumann A; Katzka DA
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2514-2523.e2. PubMed ID: 32798703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Eosinophilic Esophagitis From the European Pediatric Eosinophilic Esophagitis Registry (pEEr) of ESPGHAN.
    Oliva S; Dias JA; Rea F; Malamisura M; Espinheira MC; Papadopoulou A; Koutri E; Rossetti D; Orel R; Homan M; Bauraind O; Auth MK; Junquera CG; Vande Velde S; Kori M; Huysentruyt K; Urbonas V; Roma E; Fernández SF; Domínguez-Ortega G; Zifman E; Kafritsa P; Miele E; Zevit N;
    J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):325-333. PubMed ID: 35706095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.
    Dohil R; Newbury RO; Aceves S
    Dig Dis Sci; 2012 May; 57(5):1413-9. PubMed ID: 22134787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.